Francisco Queralt

Consejo Nacional de Investigaciones Científicas y Técnicas — Argentina

Biochemistry, Genetics and Molecular Biology · Life Sciences

3h-index116citations9works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(6), Cancer Treatment and Pharmacology(5), Angiogenesis and VEGF in Cancer(3), PI3K/AKT/mTOR signaling in cancer(3), Cancer Cells and Metastasis(2)

Publications9 total

Quality of Life in Patients with Metastatic Breast Cancer Treated with Metronomic Chemotherapy
Future Oncology·2016· 17 citedOpen Access
Abstract P3-07-61: Predictors of response and follow up biomarkers for metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients
Cancer Research·2016
Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
Cancer Chemotherapy and Pharmacology·2015· 45 cited
1562 Objective evaluation of quality of life in patients with advanced breast cancer treated with metronomic chemotherapy
European Journal of Cancer·2015· 1 cited
A new perspective in cancer treatment: Low dose metronomic chemotherapy with old known drugs in advanced breast cancer patients—Phase II clinical trial.
Journal of Clinical Oncology·2015
Abstract 4665: VEGF/SVEGFR-2 and VEGF/TSP-1 ratios as probable predictors of response to metronomic chemotherapy with Cyclophosphamide and Celecoxib in advanced breast cancer patients.
Cancer Research·2013· 1 cited
Safety and Therapeutic Effect of Metronomic Chemotherapy with Cyclophosphamide and Celecoxib in Advanced Breast Cancer Patients
Future Oncology·2013· 52 cited
Abstract 1749: Phase I/II clinical trial: Metronomic chemotherapy with cyclophosphamide (Cy) and celecoxib (Cel) in breast cancer patients progressing after standard chemotherapy
Cancer Research·2012
Metronomic chemotherapy with cyclophosphamide and celecoxib in breast cancer patients progressing after standard chemotherapy: Phase I/II trial.
Journal of Clinical Oncology·2010

Frequent Co-authors

O. Graciela Scharovsky(8), Herman Andrés Perroud(7), Carlos M. Alasino(7), María J. Rico(6), Stella Maris Pezzotto(6), Viviana R. Rozados(6), Leandro E. Mainetti(3), V. R. Rozados(3), M. Joyce Rico(2), L. E. Mainetti(2), CM Alasino(2), HA Perroud(2), SM Pezzotto(2), Mauricio Menacho-Márquez(1), S.M. Pezzotto(1), Ana Paula Rossa(1), Mauricio Ariel Menacho(1), MA Menacho-Marquez(1), Graciela Scharovsky(1)